Last reviewed · How we verify
NCT03362580
Prevalence and Risk Factors of Epiretinal Membrane in Diabetic and Non-diabetic Patients
trial testing Slit lamp examination in Epiretinal Membrane in 200 participants. Completed in 10 October 2019.
10 October 2019
Quick facts
| Lead sponsor | Laurence Postelmans |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 12 December 2017 |
| Primary completion | 10 October 2019 |
| Estimated completion | 10 October 2019 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Slit lamp examination
- Undilated 7-field color fundus photography
- Color scan
- Spectral domain optical coherence tomography
Conditions studied
- Epiretinal Membrane — all drugs for Epiretinal Membrane →
Sponsor
Laurence Postelmans
Who can join
15 and older, any sex, with Epiretinal Membrane. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Numerous terms have been used to describe epiretinal membrane (ERM): macular pucker, epimacular membrane, surface-wrinkling retinopathy, cellophane maculopathy and preretinal macular fibrosis. It is, by definition, a fibrocellular tissue found on the inner surface of the retina. It is semi-translucent and proliferates on or above the surface of the internal limiting membrane. It causes blurring and metamorphopsia, while mild cases are often asymptomatic. ERM presence can degrade the acuity and the quality of vision, thus affecting the quality of life. There is evidence that it also has an adverse impact to the treatment options for patients suffering from macular disorders. More specifically, regarding to diabetic retinopathy, ERM seems to have a bidirectional etiopathogenetic relationship with its course and complications. The aim of this study is to know the prevalence of ERM in the Brussel's population, the risk factors predisposing to ERM formation and if diabetic patients have a significantly higher prevalence of ERM in comparison to general population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03362580
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Slit lamp examination
Trials testing the same drug.
- NCT05984758 — Imaging Based Uveitis Screening for Children With Juvenile Idiopathic Arthritis · NA · not yet recruiting
- NCT05747547 — Retinal Vascular Changes in Patients After Coronavirus Disease 2019 (COVID-19) · completed
- NCT06120894 — Strip Meniscometry in Dry Eye Evaluation · completed
- NCT04292756 — Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment · NA · completed
- NCT04245072 — Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis · NA · unknown
Other recruiting trials for Epiretinal Membrane
Currently open trials in the same condition.
- NCT07019896 — Minimal Vitrectomy Surgery for Epiretinal Membrane · NA · recruiting
- NCT06719739 — Functional IOL Implantation in Patients With Epiretinal Membrane · NA · recruiting
- NCT06948851 — New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes · active not recruiting
- NCT05145491 — Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM · NA · recruiting
- NCT04306718 — Cultivation of Hyalocytes From ILM and ERM Samples: a Pilot Study · NA · active not recruiting
Other Laurence Postelmans trials
Trials by the same sponsor.
- NCT04891835 — Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (E · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03362580 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Laurence Postelmans
- Last refreshed: 9 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03362580.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing